Status:
COMPLETED
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Children's Hospital of Philadelphia
American Academy of Pediatrics
Conditions:
Influenza
COVID-19
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pedi...
Detailed Description
The study is to be conducted over the 1st season (September 2024-April 2025) as an effectiveness trial and the 2nd (September 2025-April 2026) as a replication study. This protocol covers the first se...
Eligibility Criteria
Inclusion
- Child that:
- is 6 months-17 year-old children
- due for both a COVID-19 and influenza vaccine
- Receives care at study site
- Language listed in electronic health record is English or Spanish
- Has not opted out of text messages from practice
Exclusion
- Has opted out of text messages from practice
- Language listed in electronic health record is not English or Spanish
Key Trial Info
Start Date :
October 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
66147 Patients enrolled
Trial Details
Trial ID
NCT06603090
Start Date
October 2 2024
End Date
April 30 2025
Last Update
July 11 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
American Academy of Pediatrics
Itasca, Illinois, United States, 60143
2
Columbia University Irving Medical Center
New York, New York, United States, 10032
3
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
4
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104